Oxford Biomedica (OXB) Stock Chart & Stock Price History GBX 536.17 +3.17 (+0.59%) As of 08/22/2025 11:59 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Oxford Biomedica Stock Price Performance The Oxford Biomedica (OXB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 53.19%, with a year-to-date return of 27.66%. In the past month, the stock has increased 39.99%, reflecting recent market activity. As of the latest close, Oxford Biomedica traded at GBX 536.17 with a market cap of £569.95 million and volume of 319,986 shares. Five years ago, the stock traded at GBX 822, representing a 34.77% decrease over that period. At the time, it had a market cap of £675.04 million and a volume of 55,369 shares. Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.10%1 Month Performance+39.99%3 Month Performance+67.55%Year-To-Date Performance+27.66%1 Year Performance+53.19%5 Year Performance-34.77% OXB Stock Chart for Saturday, August, 23, 2025 OXB Chart by TradingView Oxford Biomedica Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025GBX 534GBX 536.17+0.41%GBX 545GBX 494.88319,986 shs£569.95 million08/21/2025GBX 507.05GBX 534+5.32%GBX 535GBX 497.50288,237 shs£567.65 million08/20/2025GBX 503.38GBX 507.05+0.73%GBX 512GBX 494130,906 shs£539 million08/19/2025GBX 500.63GBX 503.38+0.55%GBX 510GBX 493223,522 shs£535.10 million08/18/2025GBX 494.50GBX 500.63+1.24%GBX 510GBX 489369,106 shs£532.17 million08/15/2025GBX 442.66GBX 494.50+11.71%GBX 497.08GBX 442566,818 shs£525.66 million08/14/2025GBX 441.97GBX 442.66+0.16%GBX 447.50GBX 439100,312 shs£470.55 million08/13/2025GBX 443GBX 441.97-0.23%GBX 448GBX 440.50134,702 shs£469.81 million08/12/2025GBX 430.72GBX 443+2.85%GBX 448GBX 425125,466 shs£470.91 million08/11/2025GBX 440.47GBX 430.72-2.21%GBX 450GBX 429137,733 shs£457.86 million Get the Latest News and Ratings for OXB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025GBX 441.13GBX 440.47-0.15%GBX 445GBX 43080,005 shs£468.22 million08/07/2025GBX 459.50GBX 441.13-4.00%GBX 458GBX 436.50134,403 shs£468.92 million08/06/2025GBX 459.30GBX 459.50+0.04%GBX 465GBX 454.6993,016 shs£488.45 million08/05/2025GBX 465.87GBX 459.30-1.41%GBX 470GBX 454.50102,688 shs£488.24 million08/04/2025GBX 464.50GBX 465.87+0.29%GBX 471.50GBX 449149,353 shs£495.23 million08/01/2025GBX 458.50GBX 464.50+1.31%GBX 464.50GBX 418269,333 shs£493.77 million07/31/2025GBX 458.50GBX 458.50GBX 459GBX 442.66176,752 shs£487.39 million07/30/2025GBX 429.69GBX 458.50+6.70%GBX 458.50GBX 430156,349 shs£487.39 million07/29/2025GBX 412GBX 429.69+4.29%GBX 440GBX 412279,976 shs£456.77 million07/28/2025GBX 383GBX 412+7.57%GBX 420GBX 384540,932 shs£437.96 million07/25/2025GBX 389.53GBX 383-1.68%GBX 389.50GBX 38066,971 shs£407.13 million07/24/2025GBX 383GBX 389.53+1.71%GBX 390GBX 382100,628 shs£414.08 million07/23/2025GBX 374GBX 383+2.41%GBX 385GBX 371118,896 shs£407.13 million07/22/2025GBX 375GBX 374-0.27%GBX 375GBX 35656,598 shs£397.57 million Related Companies Genus Stock Price Chart PureTech Health Stock Price Chart Faron Pharmaceuticals Oy Stock Price Chart Avacta Group Stock Price Chart Bioventix Stock Price Chart 4basebio Stock Price Chart Scancell Stock Price Chart Ondine Biomedical Stock Price Chart hVIVO Stock Price Chart SkinBioTherapeutics Stock Price Chart Receive OXB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter. This page (LON:OXB) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access